Listen to the news

European medicines regulators today backed a World Health Organization (WHO) recommendation to update the antigenic composition of COVID-19 vaccines to target one of the currently dominant variants of the XBB virus ahead of the upcoming autumn vaccination campaign.

Everything on the topic:

Coronavirus outbreak (COVID-19) 32656

WHO-affiliated advisory groups have suggested that, pending more data, monovalent vaccines containing XBB can also be considered a reasonable choice for individuals at risk of developing a serious illness, such as the elderly, who should be given priority when vaccinating, the European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) said.

EC announces treaty change with Pfizer on covid vaccines

In May, the WHO said new vaccine formulations should trigger an antibody response to the XBB.1.5 or XBB.1.16 variants, adding that other formulas that achieve a similar neutralizing response against XBB subvariants could also be considered.

More about Coronavirus

• Latest: Check out the latest news
• Easy Steps: How to Protect Yourself?
• simple guide: What are the symptoms?

The coronavirus outbreak (COVID-19)

European Union

WHO

COVID vaccines